NCT06711822View on ClinicalTrials.gov

The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification

NARecruitingINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions
Coronary Arterial Disease (CAD)Calcification; Heart
Interventions
DEVICE

Shockplus-10

Patients with coronary artery calcification who are planned to undergo PCI and are deemed in need of ShockPulse-10 treatment by their physicians

Trial Locations (1)

010

RECRUITING

Beijing Anzhen Hosipital, Beijing

Sponsors

Lead Sponsor

Keya Medical
All Listed Sponsors
lead

Keya Medical

INDUSTRY